Skip to main content

Table 1 Safety evaluation on patients between response and no-response group

From: Serum IFN-γ levels predict the therapeutic effect of mesenchymal stem cell transplantation in active rheumatoid arthritis

Measures (normal value range) No-response Response
Before treatment After treatment Before treatment After treatment
Total protein (65–85 g/L) 73.24 ± 4.32 72.52 ± 3.46 72.63 ± 5.21 74.64 ± 3.68
Albumin (40–55 g/L) 33.23 ± 5.31 32.57 ± 3.54 32.54 ± 4.63 40.63 ± 3.25*
Globulin (20–40 g/L) 30.62 ± 3.57 31.39 ± 4.36 31.58 ± 4.23 32.13 ± 3.86
Cholesterol (3.1–5.72 mmol/L) 4.03 ± 1.34 4.23 ± 1.53 4.15 ± 1.26 4.28 ± 1.93
Triglyceride (0.30–1.7 mmol/L) 1.46 ± 0.69 1.49 ± 0.83 1.51 ± 0.38 1.43 ± 0.58
Creatinine (41–73 μmol/L) 46.53 ± 13.52 45.36 ± 12.38 43.36 ± 12.78 45.25 ± 14.21
Urea (2.6–7.5 mmol/L) 4.23 ± 1.35 4.34 ± 1.28 4.12 ± 1.24 4.15 ± 1.87
Fasting blood glucose (3.9–6.1 mmol/L) 4.74 ± 0.83 4.84 ± 0.96 4.67 ± 0.73 4.75 ± 0.86
White blood cell (3.5–9.5) × 109 5.65 ± 1.35 5.78 ± 1.26 5.84 ± 1.39 5.59 ± 1.47
Hemoglobin (115–150 g/L) 102.35 ± 18.79 103.24 ± 19.21 101.15 ± 19.82 113.46 ± 16.62*
Platelet (94–268) × 109 253.23 ± 68.31 262.31 ± 72.78 263.12 ± 70.24 223.19 ± 65.87*
  1. No-response group: n = 22; Response group: n = 28
  2. Value: mean ± SEM, t test, * P < 0.05